Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Expert Financial Analysis and Reporting

Antares: Detailed Sales and Earnings Projections for 2015 and 2016 (ATRS, Buy, $2.77, subscription required)

Investment Thesis
I continue with my long standing recommendation on Antares. Last year was a disappointing year for the stock, but…
Read more…

Antares; My View of How Otrexup and Medacís New Product Rasuvo May Compete (ATRS, Buy, $2.54)

Investors Are Concerned About Rasuvoís Impact on Otrexup

Investors have been concerned about the potential effect on Otrexup if the private…
Read more…